Of course, like most things in science, it’s easier said than done. But in vivo CAR-Ts are not a far-off pipe dream. A handful of companies are pursuing them and have promising early results.

It certainly looks different, but VW has kept the core of the product simple since it entered the market in 2010 ...

They are utilised for an increasing number of commercial advanced therapy technologies, from chimeric antigen receptor (CAR) T-cell therapies to ex vivo gene therapies and, earlier last year ...

Vivo is reportedly gearing up to introduce the Vivo T4 5G in India as the successor to the Vivo T3 5G, which made its debut in the country in March 2024. According to a report by 91Mobiles citing ...

EsoBiotec’s platform has the potential to eliminate the complex and time-consuming process for manufacturing, helping to make CAR-T cell therapies more accessible.

Chiloane shared in a statement. According to Volkswagen South Africa, the Polo Vivo 55kW Vivo car is worth R271,900.